Literature DB >> 8206920

Short antisense oligonucleotide-mediated inhibition is strongly dependent on oligo length and concentration but almost independent of location of the target sequence.

B Fakler1, S Herlitze, B Amthor, H P Zenner, J P Ruppersberg.   

Abstract

The inhibitory effect of short antisense oligodeoxynucleotides (aODNs) on cRNA expression in Xenopus oocytes was measured using an electrophysiological assay based on subunit-specific block of cloned alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate receptors. The effect of both phosphorothioate-modified (PS) and phosphodiester (PO) aODNs was strongly length dependent with a half-maximal inhibition calculated for an oligo length of 7.6 nucleotides (nt) and 9.9 nt, respectively. More than 95% inhibition was mediated by a PS aODN of 12 nt and by PO aODNs > or = 15 nt. At a given length PS and PO aODNs showed differential dependence of their inhibitory effect on the injected aODN concentration (half-maximal inhibition at 18 ng/microliter for a PO 12-mer and at 0.19 ng/microliter for a PS 12-mer) and differential saturation behavior. The inhibitory effect of aODNs, even as short as 8 nt for PS oligomers, was highly sequence specific, but almost independent of the position of the respective target site on the cRNA (for PS 8-mers, > or = 70% expression inhibition throughout the tested target sites from the translation initiation to the 3'-untranslated region). Thus, short PS aODNs can be reliably used in order to specifically inhibit protein expression in experiments addressing physiological, molecular biological, and perhaps even therapeutical issues.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8206920

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

Review 1.  Molecular therapy in ocular wound healing.

Authors:  M F Cordeiro; G S Schultz; R R Ali; S S Bhattacharya; P T Khaw
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

2.  Bioavailability of antisense oligonucleotides in neuroblastoma cells: comparison of efficacy among different types of molecules.

Authors:  M V Corrias; F Guarnaccia; M Ponzoni
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

Review 3.  Strategy for designing specific antisense oligonucleotide sequences.

Authors:  M Mitsuhashi
Journal:  J Gastroenterol       Date:  1997-04       Impact factor: 7.527

4.  RNA heptamers that direct RNA cleavage by mammalian tRNA 3' processing endoribonuclease.

Authors:  M Nashimoto; S Geary; M Tamura; R Kaspar
Journal:  Nucleic Acids Res       Date:  1998-06-01       Impact factor: 16.971

5.  Tryptophan-scanning mutagenesis in the S1 domain of mammalian HCN channel reveals residues critical for voltage-gated activation.

Authors:  Takahiro M Ishii; Noriyuki Nakashima; Harunori Ohmori
Journal:  J Physiol       Date:  2006-12-21       Impact factor: 5.182

6.  A novel dual lock method for down-regulation of genes, in which a target mRNA is captured at 2 independent positions by linked locked nucleic acid antisense oligonucleotides.

Authors:  Ryohei Takata; Gouki Makado; Ayaka Kitamura; Hajime Watanabe; Tadashi Wada
Journal:  RNA Biol       Date:  2016-02-18       Impact factor: 4.652

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.